NEJM Sep 1
http://www.nejm.org/doi/full/10.1056/NEJMoa1300615?query=featured_home
"CONCLUSIONS
The use of dabigatran in patients with mechanical heart valves was associated with increased rates of thromboembolic and bleeding complications, as compared with warfarin, thus showing no benefit and an excess risk."
No comments:
Post a Comment